TrialPanorama/TrialPanorama-database huggingface dataset:
Study: NCT05736159

Intervention type: DIAGNOSTIC_TEST
Intervention: Method of assessment of school maturity
Description: Psychophysiological examination of the functional readiness of the child for admission to school.

Intervention type: DIAGNOSTIC_TEST
Intervention: Method of assessment of school maturity
Description: Psychophysiological examination of the functional readiness of the child for admission to school.

Intervention type: DIAGNOSTIC_TEST
Intervention: Method of assessment of school maturity
Description: Psychophysiological examination of the functional readiness of the child for admission to school.

Intervention type: DIAGNOSTIC_TEST
Intervention: Method of assessment of school maturity
Description: Psychophysiological examination of the functional readiness of the child for admission to school.

Intervention type: DIAGNOSTIC_TEST
Intervention: Method of assessment of school maturity
Description: Psychophysiological examination of the functional readiness of the child for admission to school.

Intervention type: DIAGNOSTIC_TEST
Intervention: Method of assessment of school maturity
Description: Psychophysiological examination of the functional readiness of the child for admission to school.

Intervention type: DIAGNOSTIC_TEST
Intervention: Method of assessment of school maturity
Description: Psychophysiological examination of the functional readiness of the child for admission to school.

Intervention type: DIAGNOSTIC_TEST
Intervention: Assessment of school adaptation
Description: Psychophysiological examination of the success of school education of first graders.

Intervention type: DIAGNOSTIC_TEST
Intervention: Assessment of school adaptation
Description: Psychophysiological examination of the success of school education of first graders.

Intervention type: DIAGNOSTIC_TEST
Intervention: Assessment of school adaptation
Description: Psychophysiological examination of the success of school education of first graders.
Study: NCT06548750

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Intrinsic and Ectrinsic Exercise
Description: Intrinsic and extrinsic muscle strengthening exercises

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Intrinsic Exercise
Description: Intrinsic muscle strengthening exercises
Study: NCT05491915

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: SPRINT Peripheral Nerve Stimulation (PNS) System
Description: The SPRINT System delivers mild electrical stimulation to the occipital nerves. The SPRINT System includes up to two leads (small wires) that are placed through your skin at the top of your neck. The leads attach to devices worn on your body that deliver stimulation (called Stimulators).
Study: NCT05103943

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: SPECT MPI
Description: SPECT MPI including dynamic acquisitions for stress, rest MBF and MFR
Study: NCT03793426

Intervention type: BIOLOGICAL
Intervention: Fibryga
Description: Human plasma-derived fibrinogen concentrate
Study: NCT04642599

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Bimanual motor skill learning with the REAplan® rehabilitation robot
Description: REAplan® rehabilitation robot: training to perform complex, coordinated, bimanual movements

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Bimanual motor skill learning with the REAplan® rehabilitation robot
Description: REAplan® rehabilitation robot: training to perform complex, coordinated, bimanual movements
Study: NCT06177028

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Lenalidomide 10 mg
Description: Lenalidomide is a cancer drug, It is also known by it's brand name Revlimid.

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Lenalidomide 10 mg
Description: Lenalidomide is a cancer drug, It is also known by it's brand name Revlimid.
Study: NCT04678323

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Lifestyle Management
Description: Participants in this group will receive lifestyle management.

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Lifestyle Management
Description: Participants in this group will receive lifestyle management.
Study: NCT04793269

Intervention type: OTHER
Intervention: No intervention
Description: no intervention
Study: NCT05597709

Intervention type: PROCEDURE
Intervention: Ultrasound attenuation parameter measurement, fasting blood glucose and fasting insulin determination
Description: Eligible participants will receive ultrasound attenuation parameter with iLivTouch, fasting blood glucose and fasting insulin determination
Study: NCT06165822

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: TQB3909 tablets
Description: TQB3909 100mg/tablet.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: TQB3909 tablets
Description: TQB3909 100mg/tablet.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Itraconazole capsule
Description: Itraconazole capsule is a strong inhibitor of CYP3A4.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Rifampicin capsule
Description: Rifampicin capsule is a strong inducer of CYP3A4.
Study: NCT04628468

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: moveUp
Description: Mobile application for use in the rehabilitation of primary knee and hip arthroplasty

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: moveUp
Description: Mobile application for use in the rehabilitation of primary knee and hip arthroplasty

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Predefined number of traditional physiotherapy sessions
Description: exercises with a physiotherapist being physically present
Study: NCT06465719

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Minimally invasive basal ganglion hematoma evacuation with Tract-based AI Robot Guiding System
Description: Basal ganglion hemorrhage patients will be operated on hematoma puncture and aspiration with Tract-based AI Robot Guiding System

Intervention type: DRUG
Group type: SHAM_COMPARATOR
Intervention: Hemocoagulase Bothrops Atrox for Injection；Nicardipine
Description: Basal ganglion hemorrhage patients will be managed with guideline-based medications without surgery. Hemocoagulase Bothrops Atrox for Injection belongs to the drug class of Hemostatic Agents. Nicardipine is a calcium channel blocker (CCB) drug to control blood pressure.
Study: NCT06259396

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: The 8x5 Diet
Description: A virtual, dietitian-counselled, healthy dietary pattern defined by its fat intake, its daily eating pattern, keeping adequately hydrated, having a variety of whole grains, fruit and vegetables, and use of certain plant fibres.
Study: NCT05267587

Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: Hypofractionated Stereotactic Radiosurgery
Description: Participants will be given hypofractionated stereotactic radiosurgery (fSRS) in 9 Gray Units (Gy) per fraction x 3 consecutive daily fractions (27 Gy total) to the index metastasis that will be resected.
Study: NCT04457076

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: LevoCept
Description: Levonorgestrel-Releasing Intrauterine System
Study: NCT05855941

Intervention type: DIAGNOSTIC_TEST
Intervention: FDG-PET/CT and FDG-PET/MRI
Description: Intravenous injection of FDG 3 MBq/kg. Intravenous injection of Dotarem 279.3 mg/ml, 0.2 ml/kg.

Intervention type: DIAGNOSTIC_TEST
Intervention: FDG-PET/CT and FDG-PET/MRI
Description: Intravenous injection of FDG 3 MBq/kg. Intravenous injection of Dotarem 279.3 mg/ml, 0.2 ml/kg.

Intervention type: DIAGNOSTIC_TEST
Intervention: FDG-PET/CT and FDG-PET/MRI
Description: Intravenous injection of FDG 3 MBq/kg. Intravenous injection of Dotarem 279.3 mg/ml, 0.2 ml/kg.
Study: NCT05702021

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Science to Service Laboratory
Description: The Science of Service Laboratory implementation strategy consists of: didactic training (contingency management workshops; monthly contingency management coaching calls), performance feedback (practice sessions and electronic medical record feedback); and facilitation (monthly facilitation calls).
Study: NCT06130501

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Sparrow Ascent tAN
Description: The Sparrow Ascent device from Spark Biomedical (Dallas, TX), applies stimulation frequencies of 15 Hz at the cymba concha (vagal innervation) and 100 Hz anterior to the tragus (trigeminal innervation). Both tAN and active sham conditions have square biphasic waveforms with identical pulse widths of 250 µs separated by a 125 µs interval between pulses. Stimulation is applied using a duty cycle of 5-minutes ON and 10 seconds OFF. The stimulation intensities (mA) will be programmed for each individual based on the highest amplitude for each channel that is both comfortable and perceptible. Patients using the device may alter the intensity of stimulation at these sites using the Patient Controller to achieve the desired effect.

Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: Sparrow Ascent Active Sham
Description: The Sparrow Ascent Active Sham is a modified version of the Sparrow Ascent tAN System that has been designed to provide sub-therapeutic stimulation to the trigeminal nerve only and no stimulation to the vagus nerve. The trigeminal nerve will receive 1 Hz stimulation at the temporomandibular region at an amplitude that is comfortable and perceptual. The pulse duration will be set to a value that does not exceed 250 μs in a square biphasic waveform. The patient controller device for the active sham will give the appearance that stimulation is being applied at both vagal and trigeminal electrode sites.
Study: NCT06480513

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: live yoga
Description: following live yoga classes twice a week and using yoga video's at home once a week

Intervention type: BEHAVIORAL
Group type: OTHER
Intervention: live remote yoga
Description: The control group will be offered live remote yoga classes after the intervention period
Study: NCT04500041

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Casting
Description: Use of casts applied using corrective maneuvers

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Bracing
Description: Use of full-time spinal orthosis
Study: NCT06038825

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: topical vibration
Description: topical vibration (Aprilla brand, giving 6000 vibrations per minute) is a device for pain relief during injection of local anesthetic.
Study: NCT05739942

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: [177Lu]Lu-NeoB
Description: Radiopharmaceutical solution for infusion

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: [177Lu]Lu-NeoB
Description: Radiopharmaceutical solution for infusion

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: [68Ga]Ga-NeoB
Description: Either provided as Kit for the radiopharmaceutical preparation of \[68Ga\]Ga-NeoB or as ready to use radiopharmaceutical solution for injection

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: [68Ga]Ga-NeoB
Description: Either provided as Kit for the radiopharmaceutical preparation of \[68Ga\]Ga-NeoB or as ready to use radiopharmaceutical solution for injection

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Temozolomide
Description: Capsules/ lyophilized powder in single-dose vial for reconstitution.
Study: NCT05977946

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Volta System
Description: The Volta System is a wearable, battery-operated, neurostimulation system designed to deliver tAN or taVNS. The device will be used to deliver two 30-minute sessions of active or sham therapy according to the participant's randomization group (taVNS or tAN).

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Volta System
Description: The Volta System is a wearable, battery-operated, neurostimulation system designed to deliver tAN or taVNS. The device will be used to deliver two 30-minute sessions of active or sham therapy according to the participant's randomization group (taVNS or tAN).
Study: NCT06105788

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Exercise
Description: Arm exercise will be an arm ergometer for 20 minutes, preceded by a 5-minute warm-up.~Leg exercise will be a cycling ergometer for 20 minutes, preceded by a 5-minute warm-up.~The exercise intensity will be set at 70% of the heart rate reserve (HRR) for each type of exercise.

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Exercise
Description: Arm exercise will be an arm ergometer for 20 minutes, preceded by a 5-minute warm-up.~Leg exercise will be a cycling ergometer for 20 minutes, preceded by a 5-minute warm-up.~The exercise intensity will be set at 70% of the heart rate reserve (HRR) for each type of exercise.
Study: NCT05366920

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: dissection of gallbladder in laparoscopic cholecystectomy
Description: Laparoscopic cholecystectomy with diathermy hook starting from triangle of Calot

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: dissection of gallbladder in laparoscopic cholecystectomy
Description: Laparoscopic cholecystectomy with diathermy hook starting from triangle of Calot

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: dissection of gallbladder in laparoscopic cholecystectomy
Description: laparoscopic cholecystectomy with 5mm suction irrigation blunt dissection starting from fundus

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: dissection of gallbladder in laparoscopic cholecystectomy
Description: laparoscopic cholecystectomy with 5mm suction irrigation blunt dissection starting from fundus
Study: NCT05958368

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Avocado
Description: The Hass Avocado group will consume 7 avocados a week (1 / day; \~240 kcals/d).

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Other Fruit(s)
Description: The other fruits group will consume fruit(s) matched to the avocado in energy and form (i.e., solid fruit).
Study: NCT05788822

Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Mevalproic acid
Description: Methovalerate pathway is a metabolism of cholesterol and isoprenoid synthesized from acetyl coenzyme A Pathway, which plays a key role in human health and disease, is also necessary for human cells to maintain normal functions. There are a series of important metabolic intermediates in the mevalproate pathway, such as farnesyl diphosphate and incense Folyl vanillin diphosphates, which modify proteins through isoprene, play an important role in regulating cell function. In addition, the latest research shows that valproic acid, the key metabolic intermediate of valproic acid pathway, being the synthetic precursor of cholesterol and isoprene, it can activate insulin growth factor (IGF)1-R and mTOR signals and maintain cell function by mediating histone function
Study: NCT06343012

Intervention type: OTHER
Group type: OTHER
Intervention: Caring leadership Intervention program
Description: Caring leadership intervention program

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Caring leadership Intervention program
Description: Caring leadership intervention program
Study: NCT05746481

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Tiragolumab
Description: Tiragolumab (an investigational novel immune checkpoint inhibitor): 600 mg IV for induction treatment administered on Day 1 of each 21-day cycle for 4 cycles. Maintenance therapy will continue with tiragolumab on Day 1 of each 21-day cycle.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Atezolizumab
Description: Atezolizumab (monoclonal antibody): 1200 mg IV administered on Day 1 of each 21-day cycle.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Pemetrexed
Description: Pemetrexed (antifolate antineoplastic agent chemotherapy): 500 mg/m2 administered IV on Day 1 of each 21-day cycle.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Carboplatin
Description: Carboplatin AUC 5 (alkylating agent chemotherapy): injection administered on Day 1 of each 21-day cycle.
Study: NCT06335524

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Finger puppet
Description: The intervention group will receive finger-puppets and additional training pertaining to infant parent interaction and developmentally appropriate infant communication training.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Bookworm reading intervention training and routine EDI care.
Description: Routine EDI care including Bookworm training.

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Bookworm reading intervention training and routine EDI care.
Description: Routine EDI care including Bookworm training.
Study: NCT04997187

Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Bacillus coagulans group
Description: Bacillus coagulans 400 mg/day for 12 weeks

Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: Control group
Description: Placebo 400 mg/day for 12 weeks
Study: NCT05200104

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: PXL065
Description: PXL065 22.5 mg QD
Study: NCT04582370

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: theater program
Description: 10-week theory-based theater program designed to improve their physical functioning and reduce emotional stress.
Study: NCT05615844

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Antibiotic Cement Bead Pouch
Description: The antibiotic bead pouch provides an antibiotic delivery mechanism. It is made by combining polymethyl methacrylate (PMMA) cement with generic forms of vancomycin and tobramycin powder.

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Negative Pressure Wound Therapy
Description: Standard application of negative pressure wound therapy
Study: NCT05589064

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Experimental: Dietetic counseling
Description: Patients will receive dietary counselling to increase caloric and nutrient intake, stabilize glycemia, and optimize hydration.

Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Active Comparator: Omega-3, vitamin D3 and creatine monohydrate
Description: Patients will be prescribed dietary supplements which will be taken daily for 8 weeks, as per the supplement protocol.

Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: Active Comparator: Omega-3, vitamin D3 and creatine monohydrate
Description: Patients will be prescribed dietary supplements which will be taken daily for 8 weeks, as per the supplement protocol.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Other : Physiotherapy treatment
Description: Patients will receive weekly physiotherapy treatment.

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Other : Physiotherapy treatment
Description: Patients will receive weekly physiotherapy treatment.

Intervention type: BEHAVIORAL
Group type: OTHER
Intervention: Other : Physiotherapy treatment
Description: Patients will receive weekly physiotherapy treatment.
Study: NCT05873569

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Mothers and Babies Virtual Group Intervention
Description: The Mothers and Babies Virtual Group (MBVG) intervention is a 10-session intervention built on principles of cognitive-behavioral therapy (CBT), attachment theory, and psychoeducation. Sessions are delivered virtually and are led by a trained MBVG facilitator.
Study: NCT06138782

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Repetitive Transcranial Magnetic Stimulation (rTMS)
Description: Our protocol consists of five treatments of inhibitory continuous TBS (cTBS) to the R OFC lasting three minutes delivered every hour over the course of 10 days (2 weeks) for a total of 50 treatments.
Study: NCT06154551

Intervention type: DIAGNOSTIC_TEST
Intervention: Paxillin biomarker
Description: Paxillin used as a salivary biomarker

Intervention type: DIAGNOSTIC_TEST
Intervention: Paxillin biomarker
Description: Paxillin used as a salivary biomarker

Intervention type: DIAGNOSTIC_TEST
Intervention: Paxillin biomarker
Description: Paxillin used as a salivary biomarker
Study: NCT05949151

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: dental implants (K1 line conical connection double thread, OXY, Italy)
Description: Six dental implants inserted on the edentulous mandible

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: dental implants (K1 line conical connection double thread, OXY, Italy)
Description: Six dental implants inserted on the edentulous mandible

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Occlusense (Bausch GmbH & Co. KG)
Description: sensor used to evaluate the equilibration of occlusal forces.

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Occlusense (Bausch GmbH & Co. KG)
Description: sensor used to evaluate the equilibration of occlusal forces.

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: electromyography (EMG) (Nemus II).
Description: EMG recordings were accomplished by a computer electromyography-based data acquisition system

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: electromyography (EMG) (Nemus II).
Description: EMG recordings were accomplished by a computer electromyography-based data acquisition system

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: oral health-related quality of life (OHRQoL)
Description: Oral Health-related Quality of Life (OHRQoL) was estimated by employing the Oral Health Impact Profile questionnaire which comprises nineteen multiple questions that were translated into Arabic.

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: oral health-related quality of life (OHRQoL)
Description: Oral Health-related Quality of Life (OHRQoL) was estimated by employing the Oral Health Impact Profile questionnaire which comprises nineteen multiple questions that were translated into Arabic.
Study: NCT05343897

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Low intensity exercise - Ping-Shuai Gong (PSG)
Description: Participants were asked to conduct and record 30 minutes of PSG in one day lasting for 2-month, and at least 3 days a week. A record sheet were sent to the participants in the first time, and the contact information of examiner were given as well. The examiner will check the completion of exercise execution via phone every two to three days and visit participants to confirm the correctness of movement at least one time during the 2-month intervention period.

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Low intensity exercise - Arm-Swing Exercise (ASE)
Description: Participants were asked to conduct and record 30 minutes of ASE in one day lasting for 2-month, and at least 3 days a week. A record sheet were sent to the participants in the first time, and the contact information of examiner were given as well. The examiner will check the completion of exercise execution via phone every two to three days and visit participants to confirm the correctness of movement at least one time during the 2-month intervention period.
Study: NCT05940610

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: MSC-EVs
Description: 10 E10 MSC-EV particles per 100ml for a single dose. Once a week for 4 weeks.